The 2018 Nobel Prize in physiology and medicine was awarded to James Allison and Tasuku Honjo for their breakthrough in cancer immunotherapy by targeting CTLA-4 and PD-1, respectively [2]. This evidence concerns the gene PDCD1 and cancer.